Multiple antigenic peptide against corona virus and immunostimulating composition containing the same
AssigneesRiken, Animal Allergy Clinical Laboratories Inc.
InventorsKenichi Masuda, Takashi Saito
Life of this patent
Estimating the term…
Abstract
The present invention provides a vaccine against a coronavirus. According to the present invention, there is provided a peptide consisting of the amino acid sequence set forth in SEQ ID NO: 1 or a partial peptide of a coronavirus spike protein consisting of the amino acid sequence corresponding to the amino acid sequence of SEQ ID NO: 1 and a multiple antigen peptide containing a plurality of any of these peptides.
Claims17
A multiple antigen peptide comprising four to eight peptides, each peptide consisting of an amino acid sequence of a coronavirus spike protein consisting of 11 consecutive amino acids set forth in SEQ ID NO:
- 7.
Dependencies are inferred from the claim text.